Lastly, one other study [51] noted that the time to metastasis was longer in patients with IDH mutations than in those without (50 versus 19 months in high-grade chondrosarcoma and 16 versus 5.5 months in dedifferentiated chondrosarcoma), although metastasis-free survival was no different. Here, IDH2 is linked to chondrosarcoma.